Myocardin is a smooth muscle and cardiac muscle-specific transcriptional coactivator of serum response factor. When expressed ectopically in nonmuscle cells, myocardin can induce smooth muscle differentiation by its association with serum response factor (SRF; MIM 600589).[supplied by OMIM][3]
References
↑Wang D, Chang PS, Wang Z, Sutherland L, Richardson JA, Small E, Krieg PA, Olson EN (Jul 2001). "Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor". Cell. 105 (7): 851–62. doi:10.1016/S0092-8674(01)00404-4. PMID11439182.
Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID14702039.
Du KL, Chen M, Li J, et al. (2004). "Megakaryoblastic leukemia factor-1 transduces cytoskeletal signals and induces smooth muscle cell differentiation from undifferentiated embryonic stem cells". J. Biol. Chem. 279 (17): 17578–86. doi:10.1074/jbc.M400961200. PMID14970199.
Wang Z, Wang DZ, Hockemeyer D, et al. (2004). "Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression". Nature. 428 (6979): 185–9. doi:10.1038/nature02382. PMID15014501.
van Tuyn J, Knaän-Shanzer S, van de Watering MJ, et al. (2006). "Activation of cardiac and smooth muscle-specific genes in primary human cells after forced expression of human myocardin". Cardiovasc. Res. 67 (2): 245–55. doi:10.1016/j.cardiores.2005.04.013. PMID15907818.
Liu ZP, Wang Z, Yanagisawa H, Olson EN (2005). "Phenotypic modulation of smooth muscle cells through interaction of Foxo4 and myocardin". Dev. Cell. 9 (2): 261–70. doi:10.1016/j.devcel.2005.05.017. PMID16054032.
Doi H, Iso T, Yamazaki M, et al. (2006). "HERP1 inhibits myocardin-induced vascular smooth muscle cell differentiation by interfering with SRF binding to CArG box". Arterioscler. Thromb. Vasc. Biol. 25 (11): 2328–34. doi:10.1161/01.ATV.0000185829.47163.32. PMID16151017.
Milyavsky M, Shats I, Cholostoy A, et al. (2007). "Inactivation of myocardin and p16 during malignant transformation contributes to a differentiation defect". Cancer Cell. 11 (2): 133–46. doi:10.1016/j.ccr.2006.11.022. PMID17292825.
Pijnappels DA, van Tuyn J, de Vries AA, et al. (2007). "Resynchronization of separated rat cardiomyocyte fields with genetically modified human ventricular scar fibroblasts". Circulation. 116 (18): 2018–28. doi:10.1161/CIRCULATIONAHA.107.712935. PMID17938287.